Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Clinical trial NCT04626024 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04626024
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Chronic Myeloid Leukemia in Remission

Start date: 2020-12-22
Primary completion: 2028-11-15
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.